US Patent 9943555 Bacteria engineered to reduce hyperphenylalaninemia
Patent 9943555 was granted and assigned to Synlogic on April, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+185 characters)
Article
Patent abstract
Genetically engineered bacteria, pharmaceutical compositions thereof, and methods of modulating and treating diseases associated with hyperphenylalaninemia are disclosed.
Edits on 1 Oct, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Dean Falb0
Jonathan W. Kotula0
Paul F. Miller0
Sarah Rowe0
Vincent M. Isabella0
Yves Millet0
Edits on 27 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09943555 Bacteria engineered to reduce hyperphenylalaninemia US Patent 9943555 Bacteria engineered to reduce hyperphenylalaninemia
Infobox
Patent Number
099435550
Patent Number
99435550
Edits on 5 Oct, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
099435550
Date of Patent
April 17, 2018
0Patent Application Number
152602110
Date Filed
September 8, 2016
0Patent Primary Examiner
Edits on 19 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09943555 Bacteria engineered to reduce hyperphenylalaninemia
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09943555
Date of patent
April 17, 2018
Patent application number
15260211
Date Filed
September 8, 2016
Patent primary examiner
Find more entities like US Patent 9943555 Bacteria engineered to reduce hyperphenylalaninemia
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.